1-8 of 8
Veena Kapoor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors

Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi, Caleph B. Wilson, Raghuveer Ranganathan, Jing Sun, Veena Kapoor, John Scholler, Ellen Puré, Michael C. Milone, Carl H. June, James L. Riley, E. John Wherry, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4262–4273.
https://doi.org/10.1158/1078-0432.CCR-13-2627
Published: 13 August 2014
View article titled, Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
Open the PDF for Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Intraoperative Near-Infrared Imaging of Surgical Wounds after Tumor Resections Can Detect Residual Disease

Brian Madajewski, Brendan F. Judy, Anas Mouchli, Veena Kapoor, David Holt, May D. Wang, Shuming Nie, Sunil Singhal
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5741–5751.
https://doi.org/10.1158/1078-0432.CCR-12-1188
Published: 14 October 2012
View article titled, Intraoperative Near-Infrared Imaging of Surgical Wounds after Tumor Resections Can Detect Residual Disease
Open the PDF for Intraoperative Near-Infrared Imaging of Surgical Wounds after Tumor Resections Can Detect Residual Disease in another window
Journal Articles

Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor

Edmund K. Moon, Carmine Carpenito, Jing Sun, Liang-Chuan S. Wang, Veena Kapoor, Jarrod Predina, Daniel J. Powell, Jr., James L. Riley, Carl H. June, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (14): 4719–4730.
https://doi.org/10.1158/1078-0432.CCR-11-0351
Published: 17 July 2011
View article titled, Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
Open the PDF for Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor in another window
Includes: Supplementary data
Journal Articles

Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers

Africa Wallace, Veena Kapoor, Jing Sun, Paul Mrass, Wolfgang Weninger, Daniel F. Heitjan, Carl June, Larry R. Kaiser, Leona E. Ling, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3966–3974.
https://doi.org/10.1158/1078-0432.CCR-08-0356
Published: 16 June 2008
View article titled, Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
Open the PDF for Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers in another window
Journal Articles

A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses

Daniel H. Sterman, Adri Recio, Richard G. Carroll, Colin T. Gillespie, Andrew Haas, Anil Vachani, Veena Kapoor, Jing Sun, Richard Hodinka, Jennifer L. Brown, Michael J. Corbley, Michael Parr, Mitchell Ho, Ira Pastan, Michael Machuzak, William Benedict, Xin-qiao Zhang, Elaina M. Lord, Leslie A. Litzky, Daniel F. Heitjan, Carl H. June, Larry R. Kaiser, Robert H. Vonderheide, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4456–4466.
https://doi.org/10.1158/1078-0432.CCR-07-0403
Published: 01 August 2007
View article titled, A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses
Open the PDF for A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses in another window
Journal Articles

Cycloxygenase-2 Inhibition Augments the Efficacy of a Cancer Vaccine

Andrew R. Haas, Jing Sun, Anil Vachani, Africa F. Wallace, Michael Silverberg, Veena Kapoor, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 214–222.
https://doi.org/10.1158/1078-0432.CCR-05-1178
Published: 05 January 2006
View article titled, Cycloxygenase-2 Inhibition Augments the Efficacy of a Cancer Vaccine
Open the PDF for Cycloxygenase-2 Inhibition Augments the Efficacy of a Cancer Vaccine in another window
Journal Articles

Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

Eiji Suzuki, Veena Kapoor, Arminder Singh Jassar, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6713–6721.
https://doi.org/10.1158/1078-0432.CCR-05-0883
Published: 15 September 2005
View article titled, Gemcitabine Selectively Eliminates Splenic Gr-1<sup>+</sup>/CD11b<sup>+</sup> Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
Open the PDF for Gemcitabine Selectively Eliminates Splenic Gr-1<sup>+</sup>/CD11b<sup>+</sup> Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity in another window
Journal Articles

Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity

Eiji Suzuki, Veena Kapoor, H.-Kam Cheung, Leona E. Ling, Peter A. DeLong, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (17): 5907–5918.
https://doi.org/10.1158/1078-0432.CCR-03-0611
Published: 08 September 2004
View article titled, Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity
Open the PDF for Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity in another window